Phase 2a trial of dazodalibep plus belatacept shows 25% acute rejection rate in kidney transplant patients
Early study tests two-drug combination to prevent kidney transplant rejection
A phase 2a, open-label, single-arm trial in 23 adults undergoing first kidney transplants evaluated dazodalibep plus belatacept as sole main…
A new two-drug kidney treatment was safe but failed to prevent rejection in most patients during this early study.
Metabolic syndrome associated with higher cardio-renal risk in kidney transplant recipients
Metabolic syndrome linked to higher risks for heart problems and kidney graft issues after transplant
A meta-analysis of 8,986 kidney transplant recipients found metabolic syndrome was associated with higher risks of major adverse cardiovascu…
Kidney transplant patients with metabolic syndrome face double the risk of major heart events and higher chances of graft failure or death.
Synbiotics Reduce Inflammation and Intestinal Permeability in Kidney Transplant Recipients
Could synbiotics help kidney transplant patients feel better and reduce inflammation?
In a trial with 46 kidney transplant recipients, synbiotic supplementation for 12 weeks significantly reduced serum LBP, hs-CRP, IL-6, and s…
For kidney transplant recipients, synbiotics may lower harmful inflammation and improve gut health. This could mean better overall health an…